Daily Aspirin: Why the Rules Changed and What It Means for You

If you've been taking a baby aspirin every morning for the last twenty years, and at your most recent visit your doctor told you to stop, you are not alone in feeling like the rules just changed without warning. For decades, an aspirin a day was the standard advice for almost any adult past middle age. Now we're walking a lot of those same patients off it. Most of them want to know two things: did the old advice hurt them, and what should they do now? I have a version of this conversation in clinic almost every week.

The short version is that the science caught up to the practice, and aspirin turned out to be a smaller help and a bigger risk than we thought, at least for people who haven't already had a heart problem. For people who have had one, aspirin is still very much part of the plan. The trick is knowing which group you fall into. That distinction is the whole game.

Two Kinds of Heart Protection

When we talk about preventing heart attacks and strokes, we use two different words for two very different situations. The words sound similar and patients understandably mix them up.

The first is primary prevention. That means trying to keep something bad from happening for the first time. You haven't had a heart attack, you haven't had a stroke, you haven't had a stent put in, you don't have known blockages in your arteries. You're trying to stay in the healthy lane.

The second is secondary prevention. That means trying to keep a second event from happening after the first one already did. You've had a heart attack, or a stroke, or a stent, or bypass surgery, or you've been told you have significant blockages in the arteries to your heart, brain, or legs. You're trying to keep the next one from coming.

Aspirin behaves like two different drugs in those two situations. In secondary prevention, the benefit is real and steady, and we keep using it. In primary prevention, the benefit turned out to be small and the bleeding risk turned out to be bigger than we'd been giving it credit for. That's the whole reason the guidance moved.

What Aspirin Actually Does to Blood

The clearest way to understand both the upside and the downside is to picture what aspirin is doing inside your bloodstream. Your blood has tiny cells called platelets. They're the first responders when a vessel gets cut. They stick together and form a plug. That's good when you nick yourself shaving. It is not good when those same platelets stick together inside a coronary artery and finish off a process that was already brewing because of cholesterol buildup. That's how most heart attacks happen.

Aspirin makes platelets less sticky. It calms them down for the entire week or so the platelet lives. The clotting plug still forms when you cut yourself, just more slowly. The same calming effect makes a clot in a coronary artery less likely to seal off the vessel. That's the protective side.

The flip side is that the same calming effect also makes any bleeding that starts harder to stop. A scrape bleeds longer. A small ulcer in the stomach bleeds more. A blood vessel that ruptures inside the brain bleeds worse. For most people, those things never happen and the trade is worth it. For some people they do happen, and aspirin tips the outcome from manageable to serious.

Why the Old Advice Made Sense at the Time

Decades ago, the studies suggesting aspirin protected against first heart attacks were exciting and the bleeding risk looked small. Doctors started recommending a daily aspirin to almost any patient with a few risk factors. Drugstores stocked low-dose 81 mg tablets in massive bottles. The advice spread from cardiology offices into primary care, and then into the public consciousness so completely that it became something you'd hear at a backyard barbecue.

A lot of those early studies were done in populations that don't look much like today's patients. Many of them were younger. Most of them were not on a statin or a blood pressure medication, because those drugs were either new or barely used. Smoking rates were higher. The background risk of having a heart attack was much higher across the board, and aspirin had a bigger problem to solve.

Modern patients are different. They're often on a statin, their blood pressure is treated, smoking rates have come down, and the background risk of a first heart attack is lower for many people. When the underlying risk is lower, the benefit of aspirin shrinks. The bleeding risk doesn't shrink with it. The math changes.

The Studies That Changed Our Minds

In 2018, three big studies came out within a few months of each other. They each looked at aspirin in primary prevention and they all pointed the same direction. One studied moderate-risk middle-aged adults. One studied people with diabetes who didn't have heart disease yet. One studied healthy older adults. None of them showed the kind of clean cardiovascular benefit that the older studies had hinted at, and all of them showed real bleeding risk. The study in healthy older adults actually found a small increase in death overall, mostly from a tick up in cancers that we still don't fully understand.

When you put those results together with everything we already knew, the picture became clearer. For older adults with no history of heart disease, taking a daily aspirin doesn't help much and probably hurts a little. The U.S. Preventive Services Task Force updated their recommendation in 2022 to reflect that. They told doctors to stop routinely starting daily aspirin in adults aged 60 and over for primary prevention, and to be cautious about it in people aged 40 to 59 unless their cardiovascular risk is high and their bleeding risk is low. Major cardiology guidelines moved the same way.

That's why your doctor may have walked you off it. The advice didn't change because we found out aspirin was poison. It changed because, for people who have never had a heart event, the modest help isn't worth the bleeding cost, especially as patients age.

Who Should Stay on Aspirin

If you've had a heart attack, you should stay on aspirin unless your doctor specifically told you otherwise.

If you've had a stent placed in a coronary artery, you should stay on aspirin. Many patients are also on a second blood thinner for a year or so after a stent, and then drop down to aspirin alone for the long haul.

If you've had bypass surgery, you should stay on aspirin.

If you've had a stroke caused by a blocked artery, or a TIA (a mini-stroke), you should stay on aspirin or a related blood thinner that your neurologist or cardiologist picked out for you.

If you have known peripheral artery disease, the kind that causes pain in your legs when you walk, you should stay on aspirin.

If you have a meaningful blockage in the carotid arteries in your neck, the ones that feed your brain, you usually stay on aspirin.

In all of these situations, the math runs the other way. The risk of another event is high enough that aspirin's protective effect is clearly worth the bleeding cost. Stopping it without a conversation is a bad idea. People who walk away from aspirin after a stent or a heart attack do worse, sometimes much worse.

Who Should Probably Stop

If you're over 60, have never had a heart event, and you've been taking a daily aspirin out of habit, that's the textbook case where the new guidance says stop. Talk to your doctor first, but don't be surprised when they agree.

If you're between 40 and 59, you haven't had a heart event, your blood pressure and cholesterol are reasonably controlled, and you don't have a strong family history or other big risk factors, the case for daily aspirin is weak. There are exceptions, and your doctor may want to look at your numbers before making a call. The default answer is no.

If you have a history of stomach ulcers, recent significant bleeding from anywhere, frequent falls, or a tendency to bruise easily, those tilt the bleeding side of the scale further. The case for stopping primary prevention aspirin gets stronger.

The Borderline Cases

A few situations sit on the edge, and these are the conversations I find most interesting in clinic.

One is the patient with a high coronary calcium score. A coronary calcium score is a low-dose CT scan that looks for calcium deposits in the walls of the arteries to your heart. A score of zero is reassuring. A score above 100 means you have meaningful plaque buildup, even if you've never had symptoms. A score above 300 means you have a lot of buildup. For some of these patients, the bar to take aspirin gets lower because the heart attack risk is genuinely higher than a basic calculator would suggest. It's a conversation, not a formula.

Another is the patient with strong family history of early heart attacks. A father who had a heart attack at 48, a sister who had one at 52, plus your own borderline cholesterol or blood pressure. The numbers on a calculator may not capture how much that family pattern matters, and a daily aspirin in your fifties may make sense in that context.

A third is the patient with elevated lipoprotein(a). That's a cholesterol particle some people inherit at high levels, and it tends to drive heart attacks earlier than the regular cholesterol numbers would predict. Knowing your lipoprotein(a) level can change the calculation for primary prevention aspirin.

In all three of these, the answer isn't automatic. It's a real shared decision between you and your doctor, weighing how much your heart attack risk is elevated against your bleeding risk.

If You Decide to Stop, How Do You Stop

Stopping aspirin is simple. There's no taper. You just stop. The blood gets back to its normal stickiness over about a week as your platelets turn over.

The day you stop, your bleeding risk drops. The risk of a heart event goes back up by a small amount, but only to where it would have been all along if you'd never started. You don't get a rebound effect that makes things worse than baseline. People sometimes worry that stopping aspirin will trigger a heart attack. That's not how the medication works.

If you stop and a few weeks later you have new chest pain or new shortness of breath that's getting worse with exertion, that's not the aspirin coming off. That's something brewing that needs to be evaluated regardless of what you're taking.

81 mg Versus 325 mg

For people who do take aspirin for cardiovascular reasons, the dose that's almost always used now is 81 mg, the so-called baby aspirin. Older studies suggested higher doses didn't help any more and bled more. There's almost no reason in modern cardiology to use 325 mg daily for prevention. If you're on the higher dose, ask your doctor whether you can drop down. Most of the time the answer is yes.

What About Cancer

A separate body of research has looked at whether daily aspirin lowers the risk of certain cancers, especially colon cancer. The signal is real for some populations, but it's not strong enough on its own to justify daily aspirin in someone with no heart disease and no special cancer risk. The cardiovascular guidelines don't account for cancer prevention in their recommendations because the evidence isn't settled. If you have a strong family history of colon cancer or a hereditary syndrome that raises your colon cancer risk, that's a conversation for your gastroenterologist or oncologist, not a reason to start daily aspirin in the absence of other indications.

Common Patient Questions

I've taken aspirin for twenty years. Did I do harm to myself?

Almost certainly not. The bleeding risk is real but small in absolute terms, and most people who take daily aspirin for years and years are fine. The reason we stop now isn't because past use was dangerous. It's because the future use isn't earning its keep.

I have a stent. My friend has heart disease and stopped aspirin. Can I stop too?

Don't compare. The right answer depends on the specifics of your case. If you have a stent, the strong default is to stay on aspirin, often for life. There are situations where a cardiologist will swap aspirin for a different blood thinner, but that's a planned change with a reason behind it, not something to do on your own.

I'm having surgery. Should I stop my aspirin before?

Sometimes yes, sometimes no, and the answer depends on what kind of surgery and why you're on aspirin. Don't decide on your own. Tell your surgeon and your cardiologist about each other and let them coordinate. If you take aspirin because of a stent, in particular, stopping it without input can be dangerous.

My stomach gets upset on aspirin. What should I do?

If you're on aspirin for a real cardiac reason, talk to your doctor about adding a stomach-protecting medication or moving to a coated form. Don't just stop on your own. If you're on aspirin for primary prevention without a clear reason, that's a good cue to ask whether you should be on it at all.

I bruise more easily than I used to. Is that the aspirin?

Often yes. Easy bruising is one of the more common signs that aspirin is doing what it's designed to do. By itself, easy bruising isn't a reason to stop if you have a real reason to be on it. If the bruising is dramatic, if you're bleeding from your gums or nose frequently, or if you see blood in your stool or urine, those need a same-day call to your doctor.

What about combining aspirin with fish oil or vitamin E?

Both can mildly increase bleeding tendency. The effect is small and rarely clinically meaningful, but it's worth telling your doctor about every supplement you take, especially before procedures or surgery.

Is there an alternative that protects without bleeding?

Not really. Anything that meaningfully reduces clotting will also increase bleeding risk to some extent. The best protection for someone with no prior heart event is the boring stuff: keeping blood pressure controlled, treating cholesterol when it's high, not smoking, exercising, eating reasonably well, and managing diabetes if you have it. Those are the moves that lower heart attack risk without exposing you to a bleeding cost.

When to Get Help Quickly

Call 911 right away for any of these on aspirin: vomiting blood, black or tarry stools, blood in the urine, sudden severe headache, sudden weakness or numbness on one side of the body, slurred speech, or a fall with a head injury. Each of those can be a sign of bleeding that needs urgent attention.

Call your doctor's office the same day for unusual gum or nose bleeding that won't stop, a new bruise the size of your hand without a clear reason, or stomach pain that started after you began aspirin and isn't going away.

Make a routine appointment soon for any of these conversations: you've been on aspirin for years and want to know if you still should be, you stopped on your own and aren't sure if you made the right call, or you're newly considering starting aspirin because of family history. None of these is an emergency. All of them are worth a focused visit.

A Final Word

The shift in aspirin guidance has frustrated a lot of patients, and I get it. For years, taking a daily baby aspirin felt like one of the few simple, cheap things you could do for your heart. Telling people to stop feels like pulling the rug out. But what we've learned, looking at the careful studies done over the past decade, is that the rug was thinner than we thought. For people who haven't had a heart attack or a stroke, the protection from aspirin is small and the bleeding cost is real, especially as we age. The newer cholesterol drugs, the better blood pressure control, and the move away from smoking have done much more for primary prevention than aspirin ever did.

If you have had a heart attack, a stent, a stroke, or a peripheral artery disease diagnosis, the conversation is completely different. Aspirin still works for you, and the evidence is rock solid. Don't let news headlines about aspirin in healthy older adults convince you to stop a medication that's protecting you from a second event.

If you're somewhere in the middle, with a strong family history or a high calcium score or some other reason to think your risk runs above average, that's where a real conversation with your doctor matters. There's no calculator that gives a clean answer for those situations. Your doctor's job is to help you weigh your risks. Your job is to be honest about your bleeding history, your other medications, and what you're willing to accept on either side. The right answer is usually obvious once you've laid the pieces out.

References

1. US Preventive Services Task Force. "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement." Journal of the American Medical Association 327, no. 16 (2022): 1577-1584.

2. Arnett, Donna K., Roger S. Blumenthal, Michelle A. Albert, Andrew B. Buroker, Zachary D. Goldberger, Ellen J. Hahn, Cheryl Dennison Himmelfarb, et al. "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease." Journal of the American College of Cardiology 74, no. 10 (2019): e177-e232.

3. Gaziano, J. Michael, Carlos Brotons, Rosa Coppolecchia, Claudio Cricelli, Harvey Darius, Philip B. Gorelick, George Howard, et al. "Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE)." The Lancet 392, no. 10152 (2018): 1036-1046.

4. Bowman, Louise, Marion Mafham, Karl Wallendszus, William Stevens, Georgina Buck, Jill Barton, Karen Murphy, et al. "Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus." New England Journal of Medicine 379, no. 16 (2018): 1529-1539.

5. McNeil, John J., Robyn L. Woods, Mark R. Nelson, Christopher M. Reid, Brenda Kirpach, Rory Wolfe, Elsdon Storey, et al. "Effect of Aspirin on All-Cause Mortality in the Healthy Elderly." New England Journal of Medicine 379, no. 16 (2018): 1519-1528.

6. Antithrombotic Trialists' Collaboration. "Aspirin in the Primary and Secondary Prevention of Vascular Disease." The Lancet 373, no. 9678 (2009): 1849-1860.

7. Lawton, Jennifer S., Jacqueline E. Tamis-Holland, Sripal Bangalore, et al. "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization." Journal of the American College of Cardiology 79, no. 2 (2022): e21-e129.

8. Kleindorfer, Dawn O., Amytis Towfighi, Seemant Chaturvedi, et al. "2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack." Stroke 52, no. 7 (2021): e364-e467.

9. Mahmoud, Ahmed N., Anthony A. Bavry, Akram Y. Elgendy, Marwan Saad. "Aspirin for the Primary Prevention of Cardiovascular Events in Patients with Diabetes." European Heart Journal 40, no. 7 (2019): 607-617.

10. Whitlock, Evelyn P., Brittany U. Burda, Selvi B. Williams, Janelle M. Guirguis-Blake, and Corinne V. Evans. "Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force." Annals of Internal Medicine 164, no. 12 (2016): 826-835.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.